Literature DB >> 34620062

CRISPR Systems Suitable for Single AAV Vector Delivery.

Marta Stevanovic1, Elena Piotter1, Michelle E McClements1, Robert E MacLaren2.   

Abstract

CRISPR (clustered regularly interspaced short palindromic repeats)/Cas gene editing is a revolutionary technology that can enable the correction of genetic mutations in vivo, providing great promise as a therapeutic intervention for inherited diseases. Adeno-associated viral (AAV) vectors are a potential vehicle for delivering CRISPR/Cas. However, they are restricted by their limited packaging capacity. Identifying smaller Cas orthologs that can be packaged, along with the required guide RNA elements, into a single AAV would be an important optimization for CRISPR/- Cas gene editing. Expanding the options of Cas proteins that can be delivered by a single AAV not only increases translational application but also expands the genetic sites that can be targeted for editing. This review considers the benefits and current scope of small Cas protein orthologs that are suitable for gene editing approaches using single AAV vector delivery. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  AAV; CRISPR; CRISPR/Cas9; Cas9; gene therapy; orthologs

Mesh:

Year:  2022        PMID: 34620062     DOI: 10.2174/1566523221666211006120355

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  5 in total

1.  Hypercompact adenine base editors based on transposase B guided by engineered RNA.

Authors:  Do Yon Kim; Yuhee Chung; Yujin Lee; Dongmin Jeong; Kwang-Hyun Park; Hyun Jung Chin; Jeong Mi Lee; Seyeon Park; Sumin Ko; Jeong-Heon Ko; Yong-Sam Kim
Journal:  Nat Chem Biol       Date:  2022-08-01       Impact factor: 16.174

Review 2.  Minicircle Delivery to the Neural Retina as a Gene Therapy Approach.

Authors:  Federica Staurenghi; Michelle E McClements; Ahmed Salman; Robert E MacLaren
Journal:  Int J Mol Sci       Date:  2022-10-02       Impact factor: 6.208

Review 3.  New CRISPR Tools to Correct Pathogenic Mutations in Usher Syndrome.

Authors:  Lauren Major; Michelle E McClements; Robert E MacLaren
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

4.  Expanding CRISPR repertoire using CjCas9 as a smaller editing tool.

Authors:  Christopher Francis; Mansoor Amiji
Journal:  Mol Ther Nucleic Acids       Date:  2022-09-30       Impact factor: 10.183

5.  In Silico Analysis of Pathogenic CRB1 Single Nucleotide Variants and Their Amenability to Base Editing as a Potential Lead for Therapeutic Intervention.

Authors:  Julia-Sophia Bellingrath; Michelle E McClements; Maria Kaukonen; Manuel Dominik Fischer; Robert E MacLaren
Journal:  Genes (Basel)       Date:  2021-11-27       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.